Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
A Better Characterization of Spinal Cord Damage in Multiple Sclerosis: A Diffusional Kurtosis Imaging Study.
Correction: MRI Correlates of Disability in African-Americans with Multiple Sclerosis.
Metabotropic glutamate receptor 5 modulates calcium oscillation and innate immune response induced by lipopolysaccharide in microglial cell.
Microglia - performers of the 21st century.
AQP4 autoantibody assay performance in clinical laboratory service.
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
[Neurological manifestations of Behçet's disease.]
Acute Disseminated Encephalomyelitis in Children and Adolescents: A Single Center Experience.
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy.
Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial.
Towards an endophenotype in multiple sclerosis.
Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
Investigation-Directed Approach to Inflammatory Optic Neuropathies.
Sedentary behaviour in people with multiple sclerosis: Is it time to stand up against MS?
Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d.
Impact of Melatonin on Motor, Cognitive and Neuroimaging Indices in Patients with Multiple Sclerosis.
Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration.
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Pages
« first
‹ previous
…
569
570
571
572
573
574
575
576
577
…
next ›
last »